Indian pharmaceutical company Dr. Reddy’s Laboratories Ltd. has teamed up with the Russian Direct Investment Fund (RDIF), to conduct clinical trials and distribute vaccine doses of the Russian Sputnik V vaccine in India.The Hyderabad-based giant said that the vaccine has shown promising results in Phase 1 and Phase 2 clinical trials.
Now, Phase 3 clinical trials will be conducted in India to meet the requirements of regulators. G.V. Prasad, co-chairman and managing director, Dr.
Read more on toopanda.com